Literature DB >> 25150037

Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis.

Husniye Baser1, Ummugulsum Can, Salih Baser, Fatma Humeyra Yerlikaya, Uysaler Aslan, Bahauddin Taha Hidayetoglu.   

Abstract

Oxidative stress results from either overproduction of free radicals or insufficiency of several anti-oxidant defense systems. It leads to oxidation of main cellular macromolecules and a resultant molecular dysfunction. Thyroid hormones regulate oxidative metabolism and, thus, play a role in free radical production. Studies evaluating oxidative stress in patients with hypothyroidism and hyperthyroidism have been encountered in recent years; however, oxidative status in patients with euthyroid autoimmune thyroiditis (AIT) was not investigated previously. Thirty-five subjects with euthyroid AIT and 35 healthy controls were enrolled in the study. Serum oxidative status was determined by the measurement of total anti-oxidant status (TAS), total oxidant status (TOS), ischemia-modified albumin (IMA), and oxidized-low density lipoprotein (ox-LDL) levels. Serum TAS levels were significantly lower (p<0.001), while serum TOS levels and IMA levels were significantly higher (p<0.001 and p=0.020, respectively) in patients compared to controls. In both groups, ox-LDL levels were similar (p=0.608). Serum TAS levels were negatively correlated with anti-thyroid peroxidase and anti-thyroglobulin (anti-TG) levels (rho=-0.415, p=0.001 and rho=-0.484, p<0.001, respectively). Serum TOS was positively correlated with anti-TG levels (rho=0.547, p<0.001). Further, TAS was positively correlated with free T4 levels (r=0.279, p=0.043). No correlation was observed between thyrotropin, free T3 levels, and TOS and TAS levels. These results suggest that oxidants are increased, and anti-oxidants are decreased in patients with euthyroid AIT, and oxidative/anti-oxidative balance is shifted to the oxidative side. Increased oxidative stress might have a role in thyroid autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25150037     DOI: 10.1007/s12020-014-0399-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  57 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinoma.

Authors:  Hüsamettin Erdamar; Behzat Cimen; Harun Gülcemal; Recep Saraymen; Betül Yerer; Hüseyin Demirci
Journal:  Clin Biochem       Date:  2010-02-18       Impact factor: 3.281

Review 3.  Protein oxidation in aging, disease, and oxidative stress.

Authors:  B S Berlett; E R Stadtman
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

4.  Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population.

Authors:  Suleyman Turedi; Orhan Cinar; Izzet Yavuz; Ahmet Mentese; Abdulkadir Gunduz; Suleyman Caner Karahan; Murat Topbas; Erdem Cevik; Ali Osman Yildirim; Ahmet Uzun; Umit Kaldirim
Journal:  J Nephrol       Date:  2010 May-Jun       Impact factor: 3.902

5.  Oxidative stress markers during a course of hyperthyroidism.

Authors:  Magdalena Lampka; Roman Junik; Anna Nowicka; Ewa Kopczyńska; Tomasz Tyrakowski; Grazyna Odrowaz-Sypniewska
Journal:  Endokrynol Pol       Date:  2006 May-Jun       Impact factor: 1.582

6.  Thyroid functions in paints production workers and the mechanism of oxidative-antioxidants status.

Authors:  Amal Saad-Hussein; Hanaa Hamdy; Hisham M Aziz; Heba Mahdy-Abdallah
Journal:  Toxicol Ind Health       Date:  2010-10-11       Impact factor: 2.273

7.  A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report.

Authors:  D Bar-Or; E Lau; J V Winkler
Journal:  J Emerg Med       Date:  2000-11       Impact factor: 1.484

8.  Effect of thyroid function on LDL oxidation in hypothyroidism and hyperthyroidism.

Authors:  Aysin Oge; E Sozmen; A O Karaoglu
Journal:  Endocr Res       Date:  2004-08       Impact factor: 1.720

9.  Inhibition of in vitro macrophage-induced low density lipoprotein oxidation by thyroid compounds.

Authors:  L Oziol; P Faure; N Bertrand; P Chomard
Journal:  J Endocrinol       Date:  2003-04       Impact factor: 4.286

10.  Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones.

Authors:  B Pereira; L F Rosa; D A Safi; E J Bechara; R Curi
Journal:  J Endocrinol       Date:  1994-01       Impact factor: 4.286

View more
  18 in total

1.  The protective effect of myo-inositol on human thyrocytes.

Authors:  Silvia Martina Ferrari; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Claudia Caruso; Salvatore Benvenga; Poupak Fallahi; Alessandro Antonelli
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

2.  Dynamic Thiol/Disulphide Homeostasis in Children and Adolescents with Non-Autoimmune Subclinical Hypothyroidism.

Authors:  Seyit Ahmet Uçaktürk; Murat Alışık; Çağatay Uğur; Selin Elmaoğulları; Eda Mengen; Özcan Erel
Journal:  Med Princ Pract       Date:  2018-01-25       Impact factor: 1.927

Review 3.  Increased risk of thyroid autoimmunity in rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Xi-Feng Pan; Jian-Qiu Gu; Zhong-Yan Shan
Journal:  Endocrine       Date:  2015-02-03       Impact factor: 3.633

4.  Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto's thyroiditis.

Authors:  R M Ruggeri; M Cristani; T M Vicchio; A Alibrandi; S Giovinazzo; A Saija; A Campennì; F Trimarchi; S Gangemi
Journal:  J Endocrinol Invest       Date:  2018-05-23       Impact factor: 4.256

5.  Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases.

Authors:  Hakan Korkmaz; Suzan Tabur; Esen Savaş; Mesut Özkaya; Şefika Nur Aksoy; Nurten Aksoy; Ersin Akarsu
Journal:  Balkan Med J       Date:  2016-09-01       Impact factor: 2.021

Review 6.  Oxidative stress in Hashimoto's thyroiditis: possible adjuvant therapies to attenuate deleterious effects.

Authors:  Gilnei Bruno da Silva; Milena Ayumi Yamauchi; Margarete Dulce Bagatini
Journal:  Mol Cell Biochem       Date:  2022-09-27       Impact factor: 3.842

Review 7.  Metabolic Characteristics of Hashimoto's Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management-An Overview.

Authors:  Aniceta A Mikulska; Marta Karaźniewicz-Łada; Dorota Filipowicz; Marek Ruchała; Franciszek K Główka
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

8.  Paraoxonase and arylesterase levels in autoimmune thyroid diseases.

Authors:  Hakan Korkmaz; Suzan Tabur; Mesut Ozkaya; Elif Oguz; Umut Elboga; Nurten Aksoy; Ersin Akarsu
Journal:  Redox Rep       Date:  2016-01-21       Impact factor: 4.412

9.  Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.

Authors:  Marcio S Medeiros; Arthur Schumacher-Schuh; Andreia Machado Cardoso; Guilherme Vargas Bochi; Jucimara Baldissarelli; Aline Kegler; Daniel Santana; Carolina Maria Martins Behle Soares Chaves; Maria Rosa Chitolina Schetinger; Rafael Noal Moresco; Carlos R M Rieder; Michele Rechia Fighera
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

10.  Reactive oxygen species in organ-specific autoimmunity.

Authors:  Giulia Di Dalmazi; Jason Hirshberg; Daniel Lyle; Joudeh B Freij; Patrizio Caturegli
Journal:  Auto Immun Highlights       Date:  2016-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.